Piper Jaffray Investment Research
Sr Research Analyst
Thomas Gunderson is a managing director and senior research analyst at Piper Jaffray, following medical technology companies. In more than 20 years as an analyst, Gunderson has been recognized by several industry publications, including The Wall Street Journal, Institutional Investor, Thomson Reuters and First Call. Most recently he was named by StarMine as the 2014 "No. 1 Stock Picker in Health Care Equipment & Supplies." He is on the Board of Directors for the Minneapolis Heart Institute Foundation, a member of the AHA's Science and Technology Accelerator Committee, and a member of the National Industry Council for the Medical Industry Leadership Institute at the University of Minnesota, and has served on the local chapter of the American Heart Association's Executive Leadership Team and on the Board of Directors for the Children's Hospitals of Minnesota Foundation. Gunderson holds a bachelor's degree from Carleton College and graduate degrees in cell biology and business administration.
Associates:Kyle Bauser, Ph.D.
Research AnalystAriel Johnson, Ph.D.
Healthcare: Medical Technology
|CMN||Cantel Medical Corp|
|ENTL||Entellus Medical, Inc.|
|ICUI||ICU Medical, Inc.|
|XENT||Intersect ENT, Inc.|
|MMSI||Merit Medical Systems, Inc.|
|SSH||Sunshine Heart, Inc.|
|TNDM||Tandem Diabetes Care, Inc.|
|VASC||Vascular Solutions, Inc.|